Aslan, O. Et Al. 2016. Dabigatran Versus Warfarin in Atrial Fibrillation: Multicenter Experience in Turkey. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.22, no.2 , 147-152.

Aslan, O., Yaylali, Y. T., Yildirim, S., Yurtdas, M., Senol, H., Ugur-Yildiz, M., ... Ozdemir, M.(2016). Dabigatran Versus Warfarin in Atrial Fibrillation: Multicenter Experience in Turkey. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.22, no.2, 147-152.

Aslan, Onur Et Al. "Dabigatran Versus Warfarin in Atrial Fibrillation: Multicenter Experience in Turkey," CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.22, no.2, 147-152, 2016

Aslan, Onur Et Al. "Dabigatran Versus Warfarin in Atrial Fibrillation: Multicenter Experience in Turkey." CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.22, no.2, pp.147-152, 2016

Aslan, O. Et Al. (2016) . "Dabigatran Versus Warfarin in Atrial Fibrillation: Multicenter Experience in Turkey." CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.22, no.2, pp.147-152.

@article{article, author={Onur Aslan Et Al. }, title={Dabigatran Versus Warfarin in Atrial Fibrillation: Multicenter Experience in Turkey}, journal={CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS}, year=2016, pages={147-152} }